Peer review reports
From: Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report
Original Submission | ||
---|---|---|
19 Mar 2020 | Submitted | Original manuscript |
25 Mar 2020 | Author responded | Author comments - Chia-Yi Tian |
Resubmission - Version 2 | ||
25 Mar 2020 | Submitted | Manuscript version 2 |
21 Apr 2020 | Reviewed | Reviewer Report - Teodora Alexa - Stratulat |
2 May 2020 | Reviewed | Reviewer Report - Hamouda Boussen |
3 May 2020 | Reviewed | Reviewer Report - Vineet Kwatra |
20 May 2020 | Author responded | Author comments - Chia-Yi Tian |
Resubmission - Version 3 | ||
20 May 2020 | Submitted | Manuscript version 3 |
25 May 2020 | Reviewed | Reviewer Report - Hamouda Boussen |
8 Jun 2020 | Reviewed | Reviewer Report - Teodora Alexa - Stratulat |
17 Jun 2020 | Author responded | Author comments - Chia-Yi Tian |
Resubmission - Version 4 | ||
17 Jun 2020 | Submitted | Manuscript version 4 |
29 Jun 2020 | Reviewed | Reviewer Report - Teodora Alexa - Stratulat |
5 Aug 2020 | Author responded | Author comments - Chia-Yi Tian |
Resubmission - Version 5 | ||
5 Aug 2020 | Submitted | Manuscript version 5 |
26 Dec 2020 | Reviewed | Reviewer Report - Teodora Alexa - Stratulat |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
8 Feb 2021 | Editorially accepted | |
30 Apr 2021 | Article published | 10.1186/s13256-021-02722-8 |